ICOS logo

Intercos Stock Price

Symbol: BIT:ICOSMarket Cap: €1.1bCategory: Household

ICOS Share Price Performance

ICOS Community Fair Values

Recent ICOS News & Updates

No updates

Intercos S.p.A. Key Details

€1.1b

Revenue

€857.9m

Cost of Revenue

€207.0m

Gross Profit

€158.5m

Other Expenses

€48.5m

Earnings

Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
Aug 04, 2025
Earnings per share (EPS)
0.50
Gross Margin
19.44%
Net Profit Margin
4.56%
Debt/Equity Ratio
50.2%

Intercos S.p.A. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About ICOS

Founded
1972
Employees
3872
CEO
Renato Semerari
WebsiteView website
www.intercos.com

Intercos S.p.A., together with its subsidiaries, creates, produces, and markets cosmetics and skin care products worldwide. The company operates through Make Up, Skincare, and Hair & Body segments. It offers foundation and concealers, highlighters, bronzers, blushes, primers, face powders, eyeshadows, delivery systems and pencils, mascara, lipsticks and glosses, nail lacquers, face and eye care products, masks, hybrids and cleansing products, body and hair care, and men grooming products, as well as creams, serums, and dermocosmetic lotions. The company sells its products to multinational brands, emerging brands, and retailers. Intercos S.p.A. was founded in 1972 and is headquartered in Agrate Brianza, Italy.

Italian Market Performance

  • 7 Days: -2.1%
  • 3 Months: 3.3%
  • 1 Year: 22.3%
  • Year to Date: 14.4%
Over the last 7 days, the market has dropped 2.1%, driven by a decline of 9.9% in the Consumer Discretionary sector. As for the longer term, the market has actually risen by 22% in the last year. Earnings are forecast to grow by 8.3% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading